A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer

NCT06343181 | Recruiting

• 1 other identifier: IEO 1824
• Study Type: observational
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

Qualitative observational study with the aim to explore medication adherence in a sample of patients with metastatic breast cancer. Patients with metastatic breast cancer receiving or having received oral oncologic therapy, and attending the Division of Medical Senology at the European Institute of Oncology, will be included and enrolled in this research project."

Conditions

Metastatic Breast Cancer

Outcome Measures

Primary Outcomes (1)

• Evaluation of factors influencing patients' adherence to medical therapy

  Collection of data in order to evaluation of factors influencing patient's adherence to medical treatment

  1 month

Study Arms (1)

Metastatic breast cancer (BC)

Patients with diagnosis of BC

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with diagnosis of metastatic breast cancer treated at European Institute of Oncology

You may qualify if:

• Age over 18 years old;
• Diagnosis of metastatic breast cancer;
• Availability of an internet connection and a PC or Tablet (for remote focus groups);
• Signing of the informed consent.

You may not qualify if:

• Presence of psychiatric or neurological conditions impairing the ability to comprehend the questions in Focus Groups or to express free consent to participate in the study;
• Presence of medical or oncological conditions other than metastatic breast cancer;
• Refusal to sign the informed consent.

Sponsors & Collaborators

• European Institute of Oncology: lead

Study Sites (1)

European Institute of Oncology

Milan, Italy

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Gabriella Pravettoni

  European Institute of Oncology

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Gabriella Pravettoni

CONTACT

+390257489731; gabriella.pravettoni@ieo.it

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 26, 2024
• First Posted: April 2, 2024
• Study Start: October 3, 2022
• Primary Completion: December 31, 2024
• Study Completion: December 31, 2024
• Last Updated: April 2, 2024

Record last verified: 2024-03

Locations

IT (1)